Cello Therapeutics
PrivateLast Round
Series A
Extension
Aug 8, 2022
Total Funding Raised
$8.65M
Company Overview
Cello Therapeutics is a biotechnology company that develops novel nanoparticle delivery platforms for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cello Therapeutics Comparables
Compare Cello Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coastar Therapeutics | 89% | |
| Duo Oncology | 82% | |
| Pendrea Bio, Inc. | 77% | |
Cello Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 8, 2022 | ||||
| Debt | May 3, 2020 | ||||
| Series A | Jun 8, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 1952% MoM, from 46 to 944.
- Jan 2, 2026
Monthly visitors increased 1470% MoM, from 46 to 722.
Cello Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cello Therapeutics's valuation, stock price, and market status.